PREVPAC Drug Patent Profile
✉ Email this page to a colleague
When do Prevpac patents expire, and when can generic versions of Prevpac launch?
Prevpac is a drug marketed by Takeda Pharms Usa and is included in one NDA.
The generic ingredient in PREVPAC is amoxicillin; clarithromycin; lansoprazole. There are forty-six drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the amoxicillin; clarithromycin; lansoprazole profile page.
Summary for PREVPAC
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for PREVPAC |
| What excipients (inactive ingredients) are in PREVPAC? | PREVPAC excipients list |
| DailyMed Link: | PREVPAC at DailyMed |
Recent Clinical Trials for PREVPAC
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Mercy Medical Center | Phase 2 |
US Patents and Regulatory Information for PREVPAC
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Takeda Pharms Usa | PREVPAC (COPACKAGED) | amoxicillin; clarithromycin; lansoprazole | CAPSULE, TABLET, CAPSULE, DELAYED REL PELLETS;ORAL | 050757-001 | Dec 2, 1997 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
